RENAL ANGIOMYOLIPOMA
Clinical trials for RENAL ANGIOMYOLIPOMA explained in plain language.
Never miss a new study
Get alerted when new RENAL ANGIOMYOLIPOMA trials appear
Sign up with your email to follow new studies for RENAL ANGIOMYOLIPOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tests everolimus for kidney tumors in TSC patients
Disease control OngoingThis study looks at how safe and effective the drug everolimus is for Taiwanese adults with tuberous sclerosis complex (TSC) who have kidney tumors called angiomyolipomas. Four participants will take the drug and be monitored for side effects and tumor shrinkage. The goal is to c…
Matched conditions: RENAL ANGIOMYOLIPOMA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New procedure aims to shrink kidney tumors without surgery
Disease control OngoingThis study tests a minimally invasive procedure that blocks blood flow to kidney angiomyolipomas (non-cancerous tumors). The goal is to shrink the tumors and stop bleeding while preserving kidney function. Researchers will follow 50 patients for one year to check safety and effec…
Matched conditions: RENAL ANGIOMYOLIPOMA
Sponsor: Botkin Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New device aims to starve tumors by cutting off their blood supply
Disease control OngoingThis study tests a device called GPX that blocks blood flow to tumors or other targeted areas. About 114 adults with conditions like kidney tumors or bone tumors will receive the treatment. The goal is to see if the device is safe and works well at reaching and blocking small blo…
Matched conditions: RENAL ANGIOMYOLIPOMA
Phase: NA • Sponsor: Fluidx Medical Technology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC